Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Use of simple pharmacokinetic modeling to characterize exposure of Australians to perfluorooctanoic acid and perfluorooctane sulfonic acid.

Thompson J, Lorber M, Toms LL, Kato K, Calafat AM, Mueller JF.

Environ Int. 2010 May;36(4):390-397. doi: 10.1016/j.envint.2010.02.008. Epub 2010 Mar 16. Erratum in: Environ Int. 2010 Aug;36(6):647-8.

PMID:
20236705
2.

Distributions of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) in Japan and their toxicities.

Nakayama S, Harada K, Inoue K, Sasaki K, Seery B, Saito N, Koizumi A.

Environ Sci. 2005;12(6):293-313. Review.

PMID:
16609670
3.

Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives.

Olsen GW, Butenhoff JL, Zobel LR.

Reprod Toxicol. 2009 Jun;27(3-4):212-30. doi: 10.1016/j.reprotox.2009.02.001. Epub 2009 Feb 20. Review.

PMID:
19429401
4.

Contamination, bioaccumulation and toxic effects of perfluorinated chemicals (PFCs) in the water environment: a review paper.

Suja F, Pramanik BK, Zain SM.

Water Sci Technol. 2009;60(6):1533-44. doi: 10.2166/wst.2009.504. Review.

PMID:
19759456
5.

Tenuous dose-response correlations for common disease states: case study of cholesterol and perfluorooctanoate/sulfonate (PFOA/PFOS) in the C8 Health Project.

Kerger BD, Copeland TL, DeCaprio AP.

Drug Chem Toxicol. 2011 Oct;34(4):396-404. doi: 10.3109/01480545.2011.582502. Epub 2011 Jul 19. Review.

PMID:
21770727

Supplemental Content

Support Center